Chris Dawson, head of TTP's Biosensing team, talks to Kayleen Brown, from the DeviceTalks podcast, about the real engineering challenges behind continuous biosensor monitoring: from power, form factor and biocompatibility constraints to robustness, reliability and system-level trade-offs.
Chris explains how strong market and domain focus enables faster, better technical decisions in highly regulated, high-stakes development, and looks ahead to what’s next in continuous monitoring, including closed-loop systems and emerging sensing approaches that could unlock entirely new analytes.
This video is an introduction to a longer podcast which features Rebecca Gottlieb, VP of Advanced Sensor Methodologies at Biolinq.
To watch the full podcast, head over to DeviceTalks - Women in MedTech.
